The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,428,268 in first-year total cost, median $244,223.
Most frequent study sections
- Career Development Study Section (J)[NCI-J]10
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
- DUKE UNIVERSITY1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF CINCINNATI1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | The Impact of Genetic Ancestry on Racial Disparities in Hepatocellular Carcinoma Risk and Mortality1K08CA255413-01A1 | JONES, PATRICIA DENISE | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $237,065 | NCI |
| 2021 | Utilization of cervical cancer prevention tools and role of high-risk HPV type in the persistent cervical cancer disparities experienced by American Indian/Alaska Native women1K08CA245200-01A1 | BRUEGL, AMANDA S | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $251,529 | NCI |
| 2021 | Targeting the DNA damage response with PARP and ATR inhibition to potentiate cytotoxicity and improve efficacy of immune checkpoint blockade in IDH mutant gliomas1K08CA258796-01 | VASQUEZ, JUAN C | YALE UNIVERSITY, CT | $231,253 | NCI |
| 2020 | Immunologic Biomarkers of Rejection in Clinical Liver Transplantation1K08CA245220-01 | EMAMAULLEE, JULIET | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $266,870 | NCI |
| 2020 | Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors1K08CA241651-01A1 | BALLESTER, LEOMAR Y | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $243,711 | NCI |
| 2020 | Harnessing Induced Human Intestinal Organoids (iHIOs) and Metagenomics to Unravel Host Immune-microbiota Interactions During Cancer Chemotherapy-associated Clostridium difficile Infections1K08CA237735-01A1 | APEWOKIN, SENU | UNIVERSITY OF CINCINNATI, OH | $233,957 | NCI |
| 2020 | Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition1K08CA237619-01A1 | LOPEZ-OLIVO, MARIA DE LOS ANGELES | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $179,849 | NCI |
| 2019 | Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach1K08CA241296-01 | ISSAKA, RACHEL B. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $288,786 | NCI |
| 2019 | Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities1K08CA241390-01 | FAYANJU, OLUWADAMILOLA M. | DUKE UNIVERSITY, NC | $244,734 | NCI |
| 2018 | Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer1K08CA234333-01 | RAUH-HAIN, JOSE ALEJANDRO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $250,514 | NCI |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.